Money · Lobbying reports · 119th Congress
H.R. 1492
41 saved lobbying reports name H.R. 1492.
41 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 10:29 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| AEGIS LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $60,000.00reported as income | April to June 2026 | Open the report |
| LMH STRATEGIC SOLUTIONS | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $30,000.00reported as income | April to June 2026 | Open the report |
| MARSHALL & POPP, LLC | AMGEN USA INC. | $60,000.00reported as income | April to June 2026 | Open the report |
| MARSHALL & POPP, LLC | GENENTECH, INC. | $60,000.00reported as income | April to June 2026 | Open the report |
| MARSHALL & POPP, LLC | PFIZER, INC. | $60,000.00reported as income | April to June 2026 | Open the report |
| MARSHALL & POPP, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $40,000.00reported as income | April to June 2026 | Open the report |
| MARSHALL & POPP, LLC | SANOFI U.S. SERVICES, INC. | $60,000.00reported as income | April to June 2026 | Open the report |
| E3 STRATEGIC CONSULTING GROUP | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | $60,000.00reported as income | April to June 2026 | Open the report |
| HEALTHCARE INSTITUTE OF NEW JERSEY | HEALTHCARE INSTITUTE OF NEW JERSEY | $47,670.00reported as expenses | April to June 2026 | Open the report |
| LUNDBECK LLC | LUNDBECK LLC | $180,000.00reported as expenses | April to June 2026 | Open the report |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $890,000.00reported as expenses | April to June 2026 | Open the report |
| TODD STRATEGY GROUP | NOVARTIS, INC. | $60,000.00reported as income | April to June 2026 | Open the report |
| ADVANCED POLICY CONSULTING, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | $40,000.00reported as income | April to June 2026 | Open the report |
| TIBER CREEK GROUP | TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) | $60,000.00reported as income | April to June 2026 | Open the report |
| CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $50,000.00reported as income | April to June 2026 | Open the report |
| THE NICKLES GROUP, LLC | NOVO NORDISK, INC. | $80,000.00reported as income | April to June 2026 | Open the report |
| THE NICKLES GROUP, LLC | MERCK & CO. INC. | $70,000.00reported as income | April to June 2026 | Open the report |
| HARMONY BIOSCIENCES | HARMONY BIOSCIENCES | $180,000.00reported as expenses | April to June 2026 | Open the report |
| PTC THERAPEUTICS, INC. | PTC THERAPEUTICS, INC. | $170,000.00reported as expenses | April to June 2026 | Open the report |
| THE MCMANUS GROUP | GILEAD SCIENCES, INC. | $60,000.00reported as income | April to June 2026 | Open the report |
| ACADIA PHARMACEUTICALS | ACADIA PHARMACEUTICALS | $700,000.00reported as expenses | April to June 2026 | Open the report |
| THE MCMANUS GROUP | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $60,000.00reported as income | April to June 2026 | Open the report |
| PUBLIC CITIZEN | PUBLIC CITIZEN | $99,577.00reported as expenses | April to June 2026 | Open the report |
| NEUROCRINE BIOSCIENCES, INC | NEUROCRINE BIOSCIENCES, INC | $940,000.00reported as expenses | April to June 2026 | Open the report |
| CHRONIC CARE POLICY ALLIANCE | CHRONIC CARE POLICY ALLIANCE | The report gives no amount | April to June 2026 | Open the report |
| NOVARTIS | NOVARTIS | $1,410,000.00reported as expenses | April to June 2026 | Open the report |
| AVENUE SOLUTIONS | GENENTECH USA, INC. | $50,000.00reported as income | April to June 2026 | Open the report |
| THE ALS ASSOCIATION | THE ALS ASSOCIATION | $30,000.00reported as expenses | April to June 2026 | Open the report |
| BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | BOEHRINGER INGELHEIM USA CORPORATION | $710,000.00reported as expenses | April to June 2026 | Open the report |
| MONUMENT ADVOCACY | PHRMA | $90,000.00reported as income | April to June 2026 | Open the report |
| NATIONAL ALLIANCE ON MENTAL ILLNESS | NATIONAL ALLIANCE ON MENTAL ILLNESS | $20,000.00reported as expenses | April to June 2026 | Open the report |
| WILLIAMS AND JENSEN, PLLC | PHRMA | $50,000.00reported as income | April to June 2026 | Open the report |
| SOLENO THERAPEUTICS, INC. | SOLENO THERAPEUTICS, INC. | $70,000.00reported as expenses | April to June 2026 | Open the report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,360,000.00reported as expenses | April to June 2026 | Open the report |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $1,440,000.00reported as expenses | April to June 2026 | Open the report |
| AMGEN, INC. | AMGEN INC | $2,440,000.00reported as expenses | April to June 2026 | Open the report |
| DLA PIPER LLP (US) | NOVARTIS | $60,000.00reported as income | April to June 2026 | Open the report |
| BAYER CORPORATION (CONSOLIDATED REPORT) | BAYER CORPORATION (CONSOLIDATED REPORT) | $1,820,000.00reported as expenses | April to June 2026 | Open the report |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY | $3,160,000.00reported as expenses | April to June 2026 | Open the report |
| BIOGEN | BIOGEN | $1,060,000.00reported as expenses | April to June 2026 | Open the report |
| EMD SERONO, INC. | EMD SERONO INC | $700,000.00reported as expenses | April to June 2026 | Open the report |